RS

Rani Shokeen

Active Director Director DIN 10634071
DIN 10634071 First appointment May 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value •••• Premium profile

About Rani Shokeen

Data last updated:

Rani Shokeen is a Director at Anglo-French Drugs & Industries Limited (since 2024). The company operates in Pharma. Anglo-French Drugs & Industries Limited reported revenue of ₹118 Cr (FY 2025).

DIN 10634071
Primary Designation Director
Industry Pharma
First Appointment 28 May 2024
Oldest Company Age 103 yrs
Largest company Anglo-French Drugs & Industries Limited · ₹118 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 May 20241923₹118 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Anglo-French Drugs & Industries Limited
Premium access

Shareholding and investment profile for Rani Shokeen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rani Shokeen

Rani Shokeen currently holds 1 directorship: Anglo-French Drugs & Industries Limited (Director, since 28 May 2024, revenue ₹118 Cr (FY 2025)).

Rani Shokeen was first appointed on 28 May 2024 as Director at Anglo-French Drugs & Industries Limited.

The current boards of Rani Shokeen's companies include Abhay Kanoria (Anglo-French Drugs & Industries Limited), Ganesh Ramgopalji Pallod (Anglo-French Drugs & Industries Limited), Manik Kumar Singh (Anglo-French Drugs & Industries Limited), Nirbhay Abhay Kanoria (Anglo-French Drugs & Industries Limited), Pradeep Vasantrao Joshi (Anglo-French Drugs & Industries Limited), Sriee Aneetha (Anglo-French Drugs & Industries Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available